Point-of-Care Diagnosis and Prognostication of Cryptococcal Meningitis With the Cryptococcal Antigen Lateral Flow Assay on Cerebrospinal Fluid

dc.contributor.author	Kabanda, Taseera
dc.contributor.author	Siedner, Mark J
dc.contributor.author	Klausner, Jeffrey D
dc.contributor.author	Muzoora, Conrad
dc.contributor.author	Boulware, David R
dc.date.accessioned	2020-02-25T06:11:30Z
dc.date.available	2020-02-25T06:11:30Z
dc.date.issued	2013
dc.identifier.citation	Kabanda, T., Siedner, M. J., Klausner, J. D., Muzoora, C., & Boulware, D. R. (2014). Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid. Clinical infectious diseases, 58(1), 113-116.	en_US
dc.identifier.uri	http://ir.must.ac.ug/xmlui/handle/123456789/510
dc.description.abstract	The cryptococcal antigen (CRAG) lateral flow assay (LFA) had 100% sensitivity and specificity on cerebrospinal fluid samples. Pretreatment LFA titers correlated with quantitative cultures (R2 = 0.7) and predicted 2- and 10-week mortality. The CRAG LFA is an accurate diagnostic assay for CSF and should be considered for point-of-care diagnosis of cryptococcal meningitis.	en_US
dc.language.iso	en	en_US
dc.publisher	Oxford University Press	en_US
dc.subject	HIV	en_US
dc.subject	cryptococcal meningitis	en_US
dc.subject	diagnosis	en_US
dc.subject	pointof-care	en_US
dc.subject	sub-Saharan Africa	en_US
dc.title	Point-of-Care Diagnosis and Prognostication of Cryptococcal Meningitis With the Cryptococcal Antigen Lateral Flow Assay on Cerebrospinal Fluid	en_US
dc.type	Article	en_US